These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 30820801

  • 1. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.
    Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG.
    J Gastrointest Surg; 2020 Feb; 24(2):368-379. PubMed ID: 30820801
    [Abstract] [Full Text] [Related]

  • 2. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
    Hoshimoto S, Hishinuma S, Shirakawa H, Tomikawa M, Ozawa I, Wakamatsu S, Hoshi S, Hoshi N, Hirabayashi K, Ogata Y.
    Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
    Han SS, Park SJ, Kim SH, Cho SY, Kim YK, Kim TH, Lee SA, Woo SM, Lee WJ, Hong EK.
    Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
    [Abstract] [Full Text] [Related]

  • 4. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
    Mierke F, Hempel S, Distler M, Aust DE, Saeger HD, Weitz J, Welsch T.
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
    Han S, Choi DW, Choi SH, Heo JS, Han IW, You YH.
    Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
    [Abstract] [Full Text] [Related]

  • 6. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
    Ramacciato G, Nigri G, Petrucciani N, Pinna AD, Ravaioli M, Jovine E, Minni F, Grazi GL, Chirletti P, Tisone G, Napoli N, Boggi U.
    Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
    [Abstract] [Full Text] [Related]

  • 7. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
    Groen JV, van Manen L, van Roessel S, van Dam JL, Bonsing BA, Doukas M, van Eijck CHJ, Farina Sarasqueta A, Putter H, Vahrmeijer AL, Verheij J, Besselink MG, Groot Koerkamp B, Mieog JSD.
    Pancreas; 2021 Sep 01; 50(8):1218-1229. PubMed ID: 34714287
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C, Dohan A, Zogopoulos G, Chiche L, Laurent C, Sa-Cunha A, Cuggia A, Reinhold C, Gallix B.
    Eur J Radiol; 2017 Oct 01; 95():33-38. PubMed ID: 28987689
    [Abstract] [Full Text] [Related]

  • 9. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
    Jeong J, Choi DW, Choi SH, Heo JS, Jang KT.
    ANZ J Surg; 2015 Apr 01; 85(4):264-9. PubMed ID: 24641800
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR, Boher JM, Sauvanet A, Le Treut YP, Sa-Cunha A, Mabrut JY, Chiche L, Turrini O, Bachellier P, Paye F.
    Ann Surg Oncol; 2015 Apr 01; 22(6):1874-83. PubMed ID: 25665947
    [Abstract] [Full Text] [Related]

  • 11. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
    Roch AM, House MG, Cioffi J, Ceppa EP, Zyromski NJ, Nakeeb A, Schmidt CM.
    J Gastrointest Surg; 2016 Mar 01; 20(3):479-87; discussion 487. PubMed ID: 26768008
    [Abstract] [Full Text] [Related]

  • 12. Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration.
    Malleo G, Maggino L, Marchegiani G, Feriani G, Esposito A, Landoni L, Casetti L, Paiella S, Baggio E, Lipari G, Capelli P, Scarpa A, Bassi C, Salvia R.
    Pancreatology; 2017 Mar 01; 17(5):847-857. PubMed ID: 28843714
    [Abstract] [Full Text] [Related]

  • 13. Defining venous involvement in borderline resectable pancreatic cancer.
    Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP.
    Ann Surg Oncol; 2010 Nov 01; 17(11):2832-8. PubMed ID: 20725860
    [Abstract] [Full Text] [Related]

  • 14. [Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?].
    Baulieux J, Adham M, Oussoultzoglou E, De la Roche E, Berthoux N, Bourdeix O, Ducerf C.
    Chirurgie; 1998 Nov 01; 123(5):438-44. PubMed ID: 9882911
    [Abstract] [Full Text] [Related]

  • 15. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.
    Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H.
    Cancer; 2012 Aug 01; 118(15):3801-11. PubMed ID: 22180096
    [Abstract] [Full Text] [Related]

  • 16. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Nagakawa Y, Jang JY, Kawai M, Kim SC, Inoue Y, Matsuyama R, Heo JS, Honda M, Sugiura T, Ohtsuka M, Mizuno S, Kwon W, Uemura K, Han HS, Sugimoto M, Okano K, Nakamura M, Wada K, Kumamoto Y, Osakae H, Tsuchida A, Yoon YS, Park JS, Yamaue H, Endo I.
    Ann Surg; 2023 May 01; 277(5):e1081-e1088. PubMed ID: 34913900
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
    Michalski CW, Kong B, Jäger C, Kloe S, Beier B, Braren R, Esposito I, Erkan M, Friess H, Kleeff J.
    BMC Surg; 2015 Aug 22; 15():100. PubMed ID: 26296752
    [Abstract] [Full Text] [Related]

  • 18. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Hirono S, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yamaue H.
    Surgery; 2016 Feb 22; 159(2):426-40. PubMed ID: 26253244
    [Abstract] [Full Text] [Related]

  • 19. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
    Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Autret A, Turrini O, Monges-Ranchin G, Boher JM.
    HPB (Oxford); 2014 Jan 22; 16(1):20-33. PubMed ID: 23464850
    [Abstract] [Full Text] [Related]

  • 20. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer.
    Zhang XM, Fan H, Kou JT, Zhang XX, Li P, Dai Y, He Q.
    J Gastroenterol Hepatol; 2016 Aug 22; 31(8):1498-503. PubMed ID: 26825612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.